NCBI PubMed Central
open access
FibroAgent: An Agentic AI Tool for Liver Fibrosis Screening and Clinical Decision Support in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- AI-driven diagnostic and prognostic models for metabolic dysfunction-associated steatotic liver disease: insights from clinical, imaging, and multi-omics studies-a scoping review.#685641
- Screening for MASLD-related Advanced Fibrosis in Type 2 Diabetes#834735
- Machine Learning Prediction of Liver Fibrosis in Patients with Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)#433288
- <b>Poster presented at EASL 2026: </b>Metabolic matters: real-world assessment of metabolic dysfunction–associated steatotic liver diseases in the United States by integrating international classification of diseases codes and non-invasive tests for improved detection#226644
- Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLD#1044771
Record · ID 152209
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive